Chemed Debt to Equity Ratio 2010-2024 | CHE

Current and historical debt to equity ratio values for Chemed (CHE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Chemed debt/equity for the three months ending September 30, 2024 was 0.00.
Chemed Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.53B $1.24B 0.43
2024-06-30 $0.53B $1.21B 0.44
2024-03-31 $0.54B $1.18B 0.46
2023-12-31 $0.56B $1.11B 0.51
2023-09-30 $0.54B $1.02B 0.53
2023-06-30 $0.55B $0.95B 0.58
2023-03-31 $0.55B $0.88B 0.63
2022-12-31 $0.64B $0.80B 0.81
2022-09-30 $0.64B $0.72B 0.88
2022-06-30 $0.63B $0.69B 0.92
2022-03-31 $0.64B $0.67B 0.96
2021-12-31 $0.72B $0.62B 1.15
2021-09-30 $0.54B $0.78B 0.69
2021-06-30 $0.51B $0.87B 0.59
2021-03-31 $0.53B $0.93B 0.57
2020-12-31 $0.53B $0.90B 0.59
2020-09-30 $0.57B $0.80B 0.71
2020-06-30 $0.54B $0.75B 0.72
2020-03-31 $0.59B $0.68B 0.87
2019-12-31 $0.54B $0.73B 0.75
2019-09-30 $0.56B $0.67B 0.83
2019-06-30 $0.48B $0.62B 0.77
2019-03-31 $0.48B $0.59B 0.82
2018-12-31 $0.38B $0.59B 0.65
2018-09-30 $0.41B $0.57B 0.72
2018-06-30 $0.37B $0.56B 0.67
2018-03-31 $0.41B $0.51B 0.80
2017-12-31 $0.38B $0.54B 0.70
2017-09-30 $0.42B $0.48B 0.88
2017-06-30 $0.46B $0.45B 1.01
2017-03-31 $0.39B $0.50B 0.77
2016-12-31 $0.36B $0.52B 0.68
2016-09-30 $0.36B $0.49B 0.73
2016-06-30 $0.39B $0.46B 0.85
2016-03-31 $0.40B $0.49B 0.82
2015-12-31 $0.34B $0.51B 0.66
2015-09-30 $0.41B $0.49B 0.84
2015-06-30 $0.41B $0.48B 0.85
2015-03-31 $0.42B $0.48B 0.88
2014-12-31 $0.41B $0.45B 0.91
2014-09-30 $0.44B $0.43B 1.01
2014-06-30 $0.40B $0.44B 0.89
2014-03-31 $0.42B $0.45B 0.95
2013-12-31 $0.45B $0.45B 0.99
2013-09-30 $0.46B $0.43B 1.07
2013-06-30 $0.42B $0.48B 0.87
2013-03-31 $0.42B $0.48B 0.86
2012-12-31 $0.41B $0.45B 0.90
2012-09-30 $0.39B $0.48B 0.82
2012-06-30 $0.38B $0.45B 0.86
2012-03-31 $0.40B $0.43B 0.91
2011-12-31 $0.38B $0.41B 0.92
2011-09-30 $0.39B $0.43B 0.91
2011-06-30 $0.36B $0.49B 0.74
2011-03-31 $0.36B $0.46B 0.77
2010-12-31 $0.37B $0.46B 0.80
2010-09-30 $0.37B $0.53B 0.68
2010-06-30 $0.35B $0.51B 0.69
2010-03-31 $0.36B $0.50B 0.72
2009-12-31 $0.34B $0.48B 0.72
2009-09-30 $0.34B $0.46B 0.75
2009-06-30 $0.34B $0.44B 0.78
2009-03-31 $0.36B $0.42B 0.86
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.853B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00